A5018663815- Hepatocellular Carcinoma Treatment and Prognosis
- Renal cell carcinoma treatment
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Cholangiocarcinoma and Gallbladder Cancer Studies
- MRI in cancer diagnosis
- Radiation Dose and Imaging
- Ultrasound and Hyperthermia Applications
- Radiomics and Machine Learning in Medical Imaging
- Pancreatic and Hepatic Oncology Research
- Venous Thromboembolism Diagnosis and Management
- Medical Imaging and Pathology Studies
- Ultrasound Imaging and Elastography
- Gallbladder and Bile Duct Disorders
- Central Venous Catheters and Hemodialysis
- Organ Transplantation Techniques and Outcomes
- Neuroendocrine Tumor Research Advances
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Ocular Oncology and Treatments
- Hepatitis B Virus Studies
- Advanced Radiotherapy Techniques
- Cancer, Lipids, and Metabolism
- Vascular Procedures and Complications
- Colorectal Cancer Treatments and Studies
Vanderbilt University Medical Center
2016-2025
Vanderbilt University
2015-2024
University of California, San Francisco
2024
University of Pittsburgh
2024
Mayo Clinic in Arizona
2023
AbbVie (United States)
2023
Bristol-Myers Squibb (Germany)
2019-2023
Infinity Pharmaceuticals (United States)
2019-2023
Novartis (Switzerland)
2019-2023
Astellas Pharma (China)
2019-2023
The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging, treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, cancer bile ducts (intrahepatic extrahepatic cholangiocarcinoma). Due to multiple modalities that can be used treat disease complications arise from comorbid liver dysfunction, a multidisciplinary evaluation is essential determining an optimal treatment strategy. A team should include hepatologists, diagnostic radiologists,...
Singal, Amit G.; Llovet, Josep M.; Yarchoan, Mark; Mehta, Neil; Heimbach, Julie K.; Dawson, Laura A.; Jou, Janice H.; Kulik, Agopian, Vatche Marrero, Jorge Mendiratta-Lala, Mishal; Brown, Daniel B.; Rilling, William S.; Goyal, Lipika; Wei, Alice C.; Taddei, Tamar H. Author Information
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations cancers of the liver, gallbladder, and bile ducts. Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data publications abstracts, reevaluate update recommendations. These Insights summarize panel's discussion most recent regarding locoregional therapy patients with hepatocellular carcinoma.
In Brief Purpose: To evaluate outcomes of downstaging patients with advanced (American liver tumor study group stage III/IV) hepatocellular carcinoma (HCC) transarterial chemoembolization (TACE) to allow eligibility for orthotopic transplant (OLT). Methods: From 1999 2006, 202 HCC were referred evaluation. Seventy-six (37.6%) III/IV potential candidates if was achieved by TACE. OLT considered based on follow-up imaging findings. The number who successfully downstaged within the Milan...
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations cancers of the liver, gallbladder, and bile ducts. Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data publications abstracts, reevaluate update recommendations. These Insights summarize panel’s discussion updated regarding systemic therapy first-line subsequent-line patients with hepatocellular carcinoma.
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The provide recommendations evaluation comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma. multidisciplinary panel experts meets at least on an annual basis to review requests from internal external entities as well evaluate new data current emerging therapies. These Insights...
Hepatic artery chemoembolization and hepatic embolization (HAE) are accepted treatments of patients with metastasis from neuroendocrine tumors. Long-term outcome data limited. We present our experience in the use treatment tumors.Forty-six carcinoid (n = 31) or islet cell 15) tumors were treated. Overall progression-free survival times starting first calculated. Potential factors affecting survival, including presence extrahepatic disease resection primary lesion, analyzed. Relief symptoms...
Wastewater surveillance for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be integrated with COVID-19 case data to inform timely pandemic response. However, more research is needed apply and develop systematic methods interpret the true SARS-CoV-2 signal from noise introduced in wastewater samples (e.g., sewer conditions, sampling extraction methods, etc.). In this study, raw was collected weekly five sewersheds one residential facility. The concentrations of were...
To evaluate safety and effectiveness of performance percutaneous vertebroplasty (PVP) in patients with malignant compression fractures involvement the epidural space.PVP was performed 50 metastatic disease or multiple myeloma between June 1998 April 2002. Twenty-five women (mean age, 62.3 years; range, 38-85 years) 25 men 63.1 37-92 were included. Cases retrospectively reviewed. Patients who had undergone cross-sectional imaging classified into three groups. First group no involvement;...
The R-matrix method has been widely employed to ab initio calculations on a large variety of problems related electron molecule scattering. UK Molecular Code, which are synthesis between codes designed for quantum chemistry and atom scattering calculations, proved particularly popular these studies but is difficult the non-specialist use. Quantemol-N software environment scientists with minimal knowledge theory or use without need complex dedicated training. Their illustrated low energy...